임상가를 위한 특집 3 - 임플란트의 새로운 응용 - 임플란트 매개 약물 전달 시스템

New Application of Endosseous Implants - Implant Mediated Drug Delivery System(IMDDS)

  • 박영석 (서울대학교 치의학대학원 구강해부학교실) ;
  • 이신재 (서울대학교 치의학대학원 치과교정학교실) ;
  • 황치일 (황치일 치과의원)
  • Park, Young-Seok (Department of Oral Anatomy, Seoul National University School of Dentistry and Dental Research Institute) ;
  • Lee, Shin-Jae (Department of Orthodontics, Seoul National University School of Dentistry) ;
  • Hwang, Chee Il (Hwang Chee Il Dental Office)
  • 투고 : 2014.07.16
  • 심사 : 2014.08.12
  • 발행 : 2014.09.01

초록

The restorative treatment with dental implants in edentulous patients has been a well documented treatment modality proven in experimental studies and long-term clinical investigations. The aim of this paper is to introduce the implant mediated drug delivery system as a novel application of endosseous implants. The system is composed of hollow cylindric implants which has multiple microholes for drug delivery. For this purpose, the general outlines of drug delivery system and drug delivery route is discussed briefly. In addition, this paper deals with the results of experiments done up to now and the future perspective of the system.

키워드

과제정보

연구 과제 주관 기관 : Korea Health Industry Development Institute (KHIDI)

참고문헌

  1. Adell R, Lekholm U, Rockler B, Brånemark P-I. A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg 1981;10:387-416. https://doi.org/10.1016/S0300-9785(81)80077-4
  2. Laney WR. The emphasis on esthetics. Int J Oral Maxillofac Implants 2001:16:625.
  3. Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P. Bannerjee SK. Drug delviery systems: an updated review. Int J Pharm Investig 2012;2:2-11. https://doi.org/10.4103/2230-973X.96920
  4. Kumar RB. "Needle free injection systems," The Pharma Innovation 2012;1:57-72.
  5. 한세광. 약물전달 시스템의 개발현황과 전망. Bioin 스페셜 Webzine 2008:3;1-16.
  6. Kos M. Association of dental and peridontal status with bisphosphonate-related osteonecrosis of the jaws. A retrospective case controlled study. Arch Med Sci 2014;10:117-123.
  7. Clark GT. Persistent orodental pain, atypical odontalgia, and phantom tooth pain: when are they neuropathic disorders? J Calif Dent Assoc 2006;34:599-609.
  8. Toumba KJ, Al-Ibrahim NS, Curzon MEJ. A review of slow-releasing fluoride devices. Eur Arch Paediat Dent 2009:10;175-182. https://doi.org/10.1007/BF03262680
  9. Dodds MWJ, Chidichimo D, Haas MS. Delivery of active agents from chewing gum for improved remineralization. Adv Dent Res 2012;24:58-62 https://doi.org/10.1177/0022034512452886
  10. Goodson JM, Holborow D, Duun RL, Hogan P, Dunham S. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol 1983;54:575-579. https://doi.org/10.1902/jop.1983.54.10.575
  11. Haidar ZS, Hamdy RC, Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering Biotechnol Lett 2009;31:1825- 1835 https://doi.org/10.1007/s10529-009-0100-8
  12. de Paula E, Cereda CMS, Fraceto F, de Araújo DR, Franz-Montan M, Tofoli GR, Ranali J, Volpato MC, Groppo F. Micro and nanosystems for delivering local anesthetics. Expert Opin Drug Deliv 2012;9:1505-1524. https://doi.org/10.1517/17425247.2012.738664
  13. Lee SK, Lee SW, Chung SC, Kim YK, Kho HS. Analysis of residual saliva and minor salivary gland secretions in patients with dry mouth. Arch Oral Biol 2002;47:637-641. https://doi.org/10.1016/S0003-9969(02)00053-5
  14. Patel VF, Liu F. Brown MB. Advances in oral transmucosal drug delivery. J Control Release 2011;153;106-116. https://doi.org/10.1016/j.jconrel.2011.01.027
  15. Hearnden V, Sankar V, Hull K, Juras DV, Greenberg M, Kerr AR, Lockhart PB, Patton LL, Porter S, Thornhill MH. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev 2012;64:16-28. https://doi.org/10.1016/j.addr.2011.02.008
  16. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053. https://doi.org/10.2337/diacare.27.5.1047
  17. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14. https://doi.org/10.1016/j.diabres.2009.10.007
  18. Park YS, Cho JY, Lee SJ, Hwang CI. Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system. Biomed Res Int 2014;2014:801358 [Epub ahead of print]